Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that neural stem/precursor cells (NPCs) promote recovery in animal models with delayed neuronal death via a number of indirect bystander effects. A comprehensive knowledge of how transplanted NPCs exert their therapeutic effects is still lacking. Here, we investigated the effects of a delayed transplantation of adult syngenic NPCs--injected intravenously 72 h after transient middle cerebral artery occlusion--on neurological recovery, histopathology and gene expression. NPC-transplanted mice showed a significantly improved recovery from 18 days post-transplantation (dpt) onwards, which persisted throughout the study. A small percentage of injected NPCs accumulated in the brain, integrating mainly in the infarct boundary zone, where most of the NPCs remained undifferentiated up to 30 dpt. Histopathological analysis revealed a hitherto unreported very delayed neuroprotective effect of NPCs, becoming evident at 10 and 30 dpt. Tissue survival was associated with downregulation of markers of inflammation, glial scar formation and neuronal apoptotic death at both mRNA and protein levels. Our data highlight the relevance of very delayed degenerative processes in the stroke brain that are intimately associated with inflammatory and glial responses. These processes may efficaciously be antagonized by (stem) cell-based strategies at time-points far beyond established therapeutic windows for pharmacological neuroprotection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, beneficial effects were reported even when treatments were initiated days, weeks, or months after stroke.14–20”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“In addition to the sprouting of pyramidal tract fibres, remodelling of transcallosal projections connecting the two motor cortices occurs.14,25”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“By contrast with neuroprotection, which requires an acute intervention, treatments promoting neurological recovery by remodelling of brain tissue can be instituted during the stroke recovery phase.10–15”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“Microvessels and neuroblasts mutually support each other via release of trophic factors, resulting in a tight interplay that stimulates brain remodelling processes, reducing delayed neuronal degeneration,14,45 promoting neuronal plasticity,15 modulating glial responses,14,46 and attenuating brain inflammation14,46 (figure 2).”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“The finding that neural precursor cells prevent ischaemic injury and promote neurological recovery could be attributed to bystander effects related to the interaction of neuroblasts with the microvasculature in the vicinity of the ischaemic lesion, which creates an environment that promotes brain remodelling (figure 2).14,15,37,45”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684 · cited 2×
“This might imply that therapies favouring endogenous tissue repair and/or remodelling may have realistic chances of success also when applied beyond established time-windows of tissue protection, which in the case of thrombolytics in humans are in the range of 3–6 h (Hacke et al., 2008).”
BackgroundPathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943 · cited 1×
“In the ischaemic border zone surrounding the evolving infarct, inflammatory responses and apoptotic programs are activated in this phase that further contribute to injury development (Dirnagl et al., 1999; Hermann et al., 2001; Hossmann, 2006).”
BackgroundWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · cited 2×
“Forty-five minutes of MCAO were induced in adult male 8- to 10-week old (weight 20–25 g) C57Bl/6 mice (Harlan Nossan, Netherlands), as previously described (Hata et al., 2000; Hermann et al., 2001).”
MethodInfluentialSelf-citationThe glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 2×
“Following the acute stroke phase, the tissue undergoes substantial matrix remodelling that results in (astro)glial scar formation, which is widely regarded as a major hampering factor for tissue repair and regeneration (Fawcett and Asher, 1999; Nedergaard and Dirnagl, 2005; Yiu and He, 2006).”
BackgroundInfluentialGlial inhibition of CNS axon regeneration
Yiu, G., & He, Z. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1956 · Cited by 1,495 · cited 2×
“Gliotic scar formation is regarded as a major factor hampering recovery from stroke (Li et al., 2005; Yiu and He, 2006).”
BackgroundInfluentialRegulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., & Veltkamp, R. (2009) · Nature Medicine · doi:10.1038/nm.1927 · Cited by 1,115 · cited 1×
“Further, the importance of both TNF- and IFN-g is emphasized by the demonstration that antagonization of the production of either of these inflammatory cytokines significantly prevented secondary infarct growth after stroke (Liesz et al., 2009).”
BackgroundInjection of adult neurospheres induces recovery in a chronic model of multiple sclerosis
Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., Galli, R., Del Carro, U., Amadio, S., Bergami, A., et al. (2003) · Nature · doi:10.1038/nature01552 · Cited by 1,068 · cited 3×
“Key functions such as the replacement of neural cells (Pluchino et al., 2003; Karimi-Abdolrezaee et al., 2006) and the delivery of therapeutic gene(s) (Lee et al., 2007) have been recently challenged by intrinsic bystander capacities, mainly exerted by undifferentiated NPCs, releasing at the site…”
BackgroundMethodInfluentialSelf-citationInterleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992 · cited 2×
“(Barone et al., 1997; Hallenbeck, 2002; Allan et al., 2005) that contribute to the detrimental post-ischaemic brain inflammation in”
BackgroundCentral nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968 · cited 2×
“…rather than immune-suppressive action exerted by NPCs may be of pivotal interest as stroke is accompanied by an early peripheral immunodeficiency phase (Meisel et al., 2005; Offner et al., 2006; Offner et al., 2009) that limits the application of systemic immunosuppressive therapies.”
BackgroundActivation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia
Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A., Tomaselli, K. J., Yuan, J., & Moskowitz, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03659.1998 · Cited by 893 · cited 3×
“That the therapeutic window is so narrow has been explained by the fact that brain infarct evolves very rapidly, typically within a few hours up to 3–4 days after stroke, depending on the duration and severity of ischaemia (Garcia et al., 1993; Namura et al., 1998; Hata et al., 2000; Li et al., 2000; Hermann et al., 2…”
BackgroundInfluential
Cited by
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Self-citationDirect generation of functional dopaminergic neurons from mouse and human fibroblasts
Caiazzo, M., Dell’Anno, M. T., Dvoretskova, E., Lazarevic, D., Taverna, S., Leo, D., Sotnikova, T. D., Menegon, A., Roncaglia, P., Colciago, G., et al. (2011) · Nature · doi:10.1038/nature10284 · Cited by 1,012
Doeppner, T. R., Herz, J., Görgens, A., Schlechter, J., Ludwig, A.-K., Radtke, S., de Miroschedji, K., Horn, P. A., Giebel, B., & Hermann, D. M. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0078 · Cited by 772
Self-citationStem cells in human neurodegenerative disorders — time for clinical translation?
Lindvall, O., & Kokaia, Z. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40543 · Cited by 614
The stem cell secretome and its role in brain repair
Drago, D., Cossetti, C., Iraci, N., Gaude, E., Musco, G., Bachi, A., & Pluchino, S. (2013) · Biochimie · doi:10.1016/j.biochi.2013.06.020 · Cited by 348
“Open access under CC for the treatment of diseases of the central nervous system (CNS), including animal models of multiple sclerosis (MS) [1e3], Alzheimer’s disease (AD) [4], spinal cord injury (SCI) [5] and stroke [6].”
BackgroundHermann, D. M., & Chopp, M. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70039-x · Cited by 333
Self-citationCross-talk between neural stem cells and immune cells: the key to better brain repair?
Kokaia, Z., Martino, G., Schwartz, M., & Lindvall, O. (2012) · Nature Neuroscience · doi:10.1038/nn.3163 · Cited by 320
Self-citationMesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases
Uccelli, A., Laroni, A., & Freedman, M. S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70121-1 · Cited by 306
Iraci, N., Leonardi, T., Gessler, F., Vega, B., & Pluchino, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020171 · Cited by 301
“In addition to cell replacement [206], we have first described significant neuroprotective and immune modulatory capacities for transplanted (undifferentiated) NSCs in vivo.”
BackgroundSelf-citationOki, K., Tatarishvili, J., Wood, J., Koch, P., Wattananit, S., Mine, Y., Monni, E., Tornero, D., Ahlenius, H., Ladewig, J., et al. (2012) · Stem Cells · doi:10.1002/stem.1104 · Cited by 293
“, modulation of inflammation [10-12], neuroprotection [12], stimulation of angiogenesis [11, 13, 14] and enhancing brain plasticity [15-17].”
Peruzzotti-Jametti, L., Bernstock, J. D., Vicario, N., Costa, A. S. H., Kwok, C. K., Leonardi, T., Booty, L. M., Bicci, I., Balzarotti, B., Volpe, G., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.01.020 · Cited by 285
“…cells, our work has shown that transplanted NSCs engage in complex stem cell graft-to-host communication programs, overall leading to trophic support and modulation of adaptive and innate immune responses (Bacigaluppi et al., 2009, 2016; Pluchino and Cossetti, 2013; Pluchino et al., 2005, 2009b).”
BackgroundSelf-citationInflammatory Disequilibrium in Stroke
Petrovic-Djergovic, D., Goonewardena, S. N., & Pinsky, D. J. (2016) · Circulation Research · doi:10.1161/circresaha.116.308022 · Cited by 265
Neural stem cells traffic functional mitochondria via extracellular vesicles
Peruzzotti-Jametti, L., Bernstock, J. D., Willis, C. M., Manferrari, G., Rogall, R., Fernandez-Vizarra, E., Williamson, J. C., Braga, A., van den Bosch, A., Leonardi, T., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001166 · Cited by 263
“Rather, fGFP-/ MitoDsRed+ mitochondria were found in both EAE mice and control nonimmunised mice close to cellular grafts, suggesting the local release and transfer of mitochondria from NSCs to host CNS cells.”
BackgroundInfluentialSelf-citationNeural Stem Cell Transplantation for Neurodegenerative Diseases
De Gioia, R., Biella, F., Citterio, G., Rizzo, F., Abati, E., Nizzardo, M., Bresolin, N., Comi, G. P., & Corti, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093103 · Cited by 247
Stonesifer, C., Corey, S., Ghanekar, S., Diamandis, Z., Acosta, S. A., & Borlongan, C. V. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.004 · Cited by 241
Tornero, D., Wattananit, S., Grønning Madsen, M., Koch, P., Wood, J., Tatarishvili, J., Mine, Y., Ge, R., Monni, E., Devaraju, K., et al. (2013) · Brain · doi:10.1093/brain/awt278 · Cited by 241
“Various mechanisms have been implicated in this process (Bacigaluppi et al., 2009), but cell therapy seems to Figure 8 Continued action potentials observed in current clamp at 0 pA. (C) Representative traces of spontaneous postsynaptic currents, and (D) spontaneous excitatory postsynaptic currents…”
BackgroundBeyond the Hippocampus and the SVZ: Adult Neurogenesis Throughout the Brain
Jurkowski, M. P., Bettio, L., K. Woo, E., Patten, A., Yau, S.-Y., & Gil-Mohapel, J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.576444 · Cited by 240
“, 2013) and the downregulation of inflammatory factors such as interferon-γ, TNF-α, and interleukins (Bacigaluppi et al., 2009; Oki et al., 2012).”
BackgroundHorie, N., Pereira, M. P., Niizuma, K., Sun, G., Keren-Gill, H., Encarnacion, A., Shamloo, M., Hamilton, S. A., Jiang, K., Huhn, S., et al. (2011) · Stem Cells · doi:10.1002/stem.584 · Cited by 240
Martino, G., Pluchino, S., Bonfanti, L., & Schwartz, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00032.2010 · Cited by 240
“, nestin) at the boundaries of the ischemic brain tissue (10).”
BackgroundSelf-citationMeta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke
Vu, Q., Xie, K., Eckert, M., Zhao, W., & Cramer, S. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000278 · Cited by 235
Cusimano, M., Biziato, D., Brambilla, E., Donegà, M., Alfaro-Cervello, C., Snider, S., Salani, G., Pucci, F., Comi, G., Garcia-Verdugo, J. M., et al. (2012) · Brain · doi:10.1093/brain/awr339 · Cited by 216
“…NPCs and inflammatory cells, was highly reminiscent of the 'atypical ectopic perivascular niche-like areas' that we previously described after systemic NPC transplantation in rodents with experimental autoimmune encephalomyelitis and stroke (Pluchino et al., 2005, 2009b; Bacigaluppi et al., 2009).”
InfluentialSelf-citationInjectable hydrogels for central nervous system therapy
Pakulska, M. M., Ballios, B. G., & Shoichet, M. S. (2012) · Biomedical Materials · doi:10.1088/1748-6041/7/2/024101 · Cited by 216
Stem Cell-Based Therapies for Ischemic Stroke
Hao, L., Zou, Z., Tian, H., Zhang, Y., Zhou, H., & Liu, L. (2014) · BioMed Research International · doi:10.1155/2014/468748 · Cited by 214
Neural stem cell therapy for subacute and chronic ischemic stroke
Boese, A. C., Le, Q.-S. E., Pham, D., Hamblin, M. H., & Lee, J.-P. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0913-2 · Cited by 205
“For example, hiPSC-NSC transplantation results in significantly lower amounts of Iba-1+ and ED1+ cells within and around the ischemic core in the stroke mouse model [207].”
InfluentialPreconditioning Strategy in Stem Cell Transplantation Therapy
Yu, S. P., Wei, Z., & Wei, L. (2013) · Translational Stroke Research · doi:10.1007/s12975-012-0251-0 · Cited by 190
Chen, S.-J., Chang, C.-M., Tsai, S.-K., Chang, Y.-L., Chou, S.-J., Huang, S.-S., Tai, L.-K., Chen, Y.-C., Ku, H.-H., Li, H.-Y., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0452 · Cited by 187
“Recent studies demonstrated that hematopoietic stem cells and neural stem cells reduce cerebral infl ammation in ischemic brain injury [ 22 , 23 ].”
Darsalia, V., Allison, S. J., Cusulin, C., Monni, E., Kuzdas, D., Kallur, T., Lindvall, O., & Kokaia, Z. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.81 · Cited by 184
“Second, stem cells can ameliorate poststroke impairments in the rodent brain also by modulating inflammation, inducing angiogenesis, and by providing neuroprotection (Lee et al, 2007; Bacigaluppi et al, 2009; Liu et al, 2009).”
BackgroundDe Feo, D., Merlini, A., Laterza, C., & Martino, G. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328352ec45 · Cited by 181
Self-citationCell based therapies for ischemic stroke: From basic science to bedside
Liu, X., Ye, R., Yan, T., Yu, S. P., Wei, L., Xu, G., Fan, X., Jiang, Y., Stetler, R. A., Liu, G., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.007 · Cited by 179
The dark side of the force – constraints and complications of cell therapies for stroke
Boltze, J. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00155 · Cited by 175
“(rodents) (19, 20) 16μm (2150μm(3)) Improved functional recovery Allogeneic”
BackgroundStem Cell Research in Stroke: How Far From the Clinic?
Lindvall, O., & Kokaia, Z. (2011) · Stroke · doi:10.1161/strokeaha.110.599654 · Cited by 176
“Наконец, внутривенное введение мышиных НСК мышам через 3 дня после инсульта привело к подавлению воспаления и формированию глиального рубца, что способствовало отсроченной нейропротекции и улучшению функционального восстановления, начиная с 18-го дня после инсульта [27].”
Donega, V., Nijboer, C. H., van Tilborg, G., Dijkhuizen, R. M., Kavelaars, A., & Heijnen, C. J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.009 · Cited by 175
“The capacity of stem cells to treat neonatal encephalopathy is gaining support from an increasing number of studies (Bacigaluppi et al., 2009; Daadi et al., 2010; Donega et al., 2013a; Lee et al., 2010; Pimentel-Coelho et al., 2010; Titomanlio et al., 2011; Yasahura et al., gy, Department of…”
BackgroundLeong, W. K., Henshall, T. L., Arthur, A., Kremer, K. L., Lewis, M. D., Helps, S. C., Field, J., Hamilton-Bruce, M. A., Warming, S., Manavis, J., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0039 · Cited by 173
Zagrean, A.-M., Hermann, D. M., Opris, I., Zagrean, L., & Popa-Wagner, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00811 · Cited by 171
Self-citationMinocycline-Preconditioned Neural Stem Cells Enhance Neuroprotection after Ischemic Stroke in Rats
Sakata, H., Niizuma, K., Yoshioka, H., Kim, G. S., Jung, J. E., Katsu, M., Narasimhan, P., Maier, C. M., Nishiyama, Y., & Chan, P. H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5686-11.2012 · Cited by 168
Yousefifard, M., Rahimi-Movaghar, V., Nasirinezhad, F., Baikpour, M., Safari, S., Saadat, S., Moghadas Jafari, A., Asady, H., Razavi Tousi, S. M. T., & Hosseini, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.034 · Cited by 166
“These cells can also modulate immune and inflammatory responses (Lee et al., 2008a; Bacigaluppi et al., 2009; Ottoboni et al., 2015).”
BackgroundWang, C., Börger, V., Sardari, M., Murke, F., Skuljec, J., Pul, R., Hagemann, N., Dzyubenko, E., Dittrich, R., Gregorius, J., et al. (2020) · Stroke · doi:10.1161/strokeaha.119.028012 · Cited by 158
“We herein show that MSC-derived sEVs induce postischemic neuroprotection, when administered in the acute stroke phase in mice exposed to intraluminal MCAO.”
MethodSelf-citationReitmeir, R., Kilic, E., Kilic, Ü., Bacigaluppi, M., ElAli, A., Salani, G., Pluchino, S., Gassmann, M., & Hermann, D. M. (2011) · Brain · doi:10.1093/brain/awq344 · Cited by 156
“…of glial scar formation has previously been reported in studies evaluating cell-based therapies, namely bone marrow-derived stem cells (Li et al., 2005) and adult neural precursor cells (Bacigaluppi et al., 2009), indicating that erythropoietin shares common mechanisms of action with these cells.”
InfluentialSelf-citationFunctional dissection of astrocyte-secreted proteins: Implications in brain health and diseases
Jha, M. K., Kim, J.-H., Song, G. J., Lee, W., Lee, I. K., Lee, H., An, S. S. A., Kim, S., & Suk, K. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.12.003 · Cited by 167
“…the end of the first week following an acute stroke injury, is associated with a cascade of reorganization events, including synaptogenesis (Jones and Bouvier, 2014), angiogenesis (Xiong et al., 2010), astrocytosis inhibition (Li et al., 2005), and anti-inflammation (Bacigaluppi et al., 2009) (Fig.”
BackgroundShin, J. C., Kim, K. N., Yoo, J., Kim, I., Yun, S., Lee, H.-J., Jung, K., Hwang, K., Kim, M., Lee, I.-S., et al. (2015) · Neural Plasticity · doi:10.1155/2015/630932 · Cited by 150
Stem cell therapy for neonatal brain injury: Perspectives and Challenges
Titomanlio, L., Kavelaars, A., Dalous, J., Mani, S., Ghouzzi, V. E., Heijnen, C. J., Baud, O., & Gressèns, P. (2011) · Annals of Neurology · doi:10.1002/ana.22518 · Cited by 141
Shekhar, S., Cunningham, M., Pabbidi, M. R., Wang, S., Booz, G. W., & Fan, F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.028 · Cited by 137
Mine, Y., Tatarishvili, J., Oki, K., Monni, E., Kokaia, Z., & Lindvall, O. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.12.006 · Cited by 136
How stem cells speak with host immune cells in inflammatory brain diseases
Pluchino, S., & Cossetti, C. (2013) · Glia · doi:10.1002/glia.22500 · Cited by 125
“…biological fluids (blood stream, cerebrospinal fluid and lymph) of rodents or non-human primates with either chronic and relapsing EAE or stroke (Bacigaluppi et al., 2009; Capone et al., 2007; Daadi et al., 2010; Lee et al., 2008), thus reducing the amount of demyelination and axonal/neuronal…”
BackgroundGullotta, G. S., Feo, D. D., Friebel, E., Semerano, A., Scotti, G. M., Bergamaschi, A., Butti, E., Brambilla, E., Genchi, A., Capotondo, A., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01505-1 · Cited by 136
Self-citationMemantine Enhances Recovery From Stroke
López-Valdés, H. E., Clarkson, A. N., Ao, Y., Charles, A. C., Carmichael, S. T., Sofroniew, M. V., & Brennan, K. C. (2014) · Stroke · doi:10.1161/strokeaha.113.004476 · Cited by 132
“Our observation of a decrease in GFAP immunoreactivity in peri-infarct cortex after memantine treatment is consistent with other reports associating improved stroke recovery with reduced astrocytic reactivity.(43,44) Moreover, in a similar animal model, BDNF treatment was associated with a significant decrease in astr…”
ResultHuman umbilical cord blood mesenchymal stem cells protect mice brain after trauma*
Zanier, E. R., Montinaro, M., Vigano, M., Villa, P., Fumagalli, S., Pischiutta, F., Longhi, L., Leoni, M. L., Rebulla, P., Stocchetti, N., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822629ba · Cited by 118
“Recent studies show that stem cell infusion is able to dampen gliotic scar formation after cortical injury (52, 53) and brain ischemia (54).”
BackgroundRemote control of induced dopaminergic neurons in parkinsonian rats
Dell’Anno, M. T., Caiazzo, M., Leo, D., Dvoretskova, E., Medrihan, L., Colasante, G., Giannelli, S. G., Theka, I., Russo, G., Mus, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74664 · Cited by 128
Neural stem cell therapy for stroke: A multimechanistic approach to restoring neurological function
Baker, E. W., Kinder, H. A., & West, F. D. (2019) · Brain and Behavior · doi:10.1002/brb3.1214 · Cited by 120
Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice
Sakata, H., Narasimhan, P., Niizuma, K., Maier, C. M., Wakai, T., & Chan, P. H. (2012) · Brain · doi:10.1093/brain/aws259 · Cited by 113
“Furthermore, we cannot exclude the possibility that other mechanisms of stem cell action, such as immunomodulation and cell replacement, are enhanced by IL-6 preconditioning (Kelly et al., 2004; Bacigaluppi et al., 2009).”
BackgroundTang, Y., Wang, J., Lin, X., Wang, L., Shao, B., Jin, K., Wang, Y., & Yang, G.-Y. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.61 · Cited by 113
Bacigaluppi, M., Russo, G. L., Peruzzotti-Jametti, L., Rossi, S., Sandrone, S., Butti, E., De Ceglia, R., Bergamaschi, A., Motta, C., Gallizioli, M., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1643-16.2016 · Cited by 108
Self-citationVishwakarma, S. K., Bardia, A., Tiwari, S. K., Paspala, S. A. B., & Khan, A. A. (2013) · Journal of Advanced Research · doi:10.1016/j.jare.2013.04.005 · Cited by 113
Beker, M. Ç., Çağlayan, B., Yalçın, E., Çağlayan, A. B., Türkseven, Ş., Gürel, B., Keleştemur, T., Sertel, E., Şahin, Z., Kutlu, S., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0524-4 · Cited by 114
Hypoxia in the regulation of neural stem cells
Filippis, L. D., & Delia, D. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0723-5 · Cited by 121
“Several studies have revealed that adult-derived neural progenitor and stem cells offer neuroprotection by an immunomodulatory mechanism [10, 76, 77].”
BackgroundHuman Umbilical Cord Blood Cells Restore Brain Damage Induced Changes in Rat Somatosensory Cortex
Geißler, M., Dinse, H. R., Neuhoff, S., Kreikemeier, K., & Meier, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020194 · Cited by 105
Brifault, C., Gras, M., Liot, D., May, V., Vaudry, D., & Wurtz, O. (2015) · Stroke · doi:10.1161/strokeaha.114.006864 · Cited by 102
“Numerous studies report beneficial effects of stem cell transplantation after stroke because of their ability to produce antiapoptotic, neurotrophic, and immunomodulatory factors.(20) In our model, the transplantation of nonmodified stem cells does not promote functional recovery at 7 and 14 dpi, suggesting that these…”
BackgroundHill, J. J., Jin, K., Mao, X. O., Xie, L., & Greenberg, D. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205697109 · Cited by 101
“Spot count and surfaces were calculated for each image, for MAP2 and 9158 | www.pnas.org/cgi/doi/10.1073/pnas.1205697109 Hill et al. D ow nl oa de d by g ue st o n M ay 2 4, 2 02 1 GFAP, respectively, using Bitplane Imaris 7.0 software (Bitplane Scientific Software) (44).”
InfluentialBernstock, J. D., Peruzzotti‐Jametti, L., Ye, D. G., Gessler, F. A., Maric, D., Vicario, N., Lee, Y.-J., Pluchino, S., & Hallenbeck, J. M. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17700432 · Cited by 109
“The exogenous approach – on which we have predominately focused our collective experimental attention – instead involves the transplantation of NSCs obtained from an independent source.(17,18) These exogenous NSCs have the potential to serve as a virtually unlimited source of new neural cells, and via their innate abi…”
BackgroundHuang, Y., Wang, J., Cai, J., Qiu, Y., Zheng, H., Lai, X., Sui, X. Y., Wang, Y., Lu, Q., Zhang, Y., et al. (2018) · Theranostics · doi:10.7150/thno.28029 · Cited by 106
Therapeutic Plasticity of Neural Stem Cells
Ottoboni, L., von Wunster, B., & Martino, G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00148 · Cited by 99
“This was originally demonstrated in mice with primary inflammatory disorders, including the animal model of MS (173, 181) or stroke (182, 183) and in mice with neurodegenerative diseases mediated by reactive inflammation, such as Parkinson’s Disease (184).”
BackgroundSelf-citationCooke, M. J., Vulic, K., & Shoichet, M. S. (2010) · Soft Matter · doi:10.1039/c0sm00448k · Cited by 108
Stem Cell Therapy and Administration Routes After Stroke
Rodríguez‐Frutos, B., Otero‐Ortega, L., Gutiérrez‐Fernández, M., Fuentes, B., Ramos‐Cejudo, J., & Díez‐Tejedor, E. (2016) · Translational Stroke Research · doi:10.1007/s12975-016-0482-6 · Cited by 106
“Most of these exogenous cells remained undifferentiated, however, up to 30 days after intravenous administration [56].”
The role of neurogenesis in neurorepair after ischemic stroke
Marques, B. L., Carvalho, G. A., Freitas, E. M. M., Chiareli, R. A., Barbosa, T. G., Araújo, A. G. P. D., Nogueira, Y. L., Ribeiro, R. I., Parreira, R. C., Vieira, M. S., et al. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.12.003 · Cited by 105
Stem Cell–Based Tissue Replacement After Stroke: Factual Necessity or Notorious Fiction?
Janowski, M., Wagner, D., & Boltze, J. (2015) · Stroke · doi:10.1161/strokeaha.114.007803 · Cited by 99
Optimizing Stem Cell Therapy after Ischemic Brain Injury
Zhang, S., Lachance, B. B., Moiz, B., & Jia, X. (2020) · Journal of Stroke · doi:10.5853/jos.2019.03048 · Cited by 94
“Administration of human NSCs in a stroke rat model revealed neuroprotective effects by increasing dendritic branching, enhancing corticospinal tract projections, and inhibiting inflammation.(42,43) Additionally, an in vitro and in vivo study has suggested that improved functional outcomes in stroke rats treated with t…”
BackgroundDoeppner, T. R., Kaltwasser, B., Bähr, M., & Hermann, D. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00338 · Cited by 89
“Transplantation of NPCs using either systemic or local cell delivery routes reduces post-ischemic injury (Mochizuki et al., 2008; Bacigaluppi et al., 2009; Hicks et al., 2009; Doeppner et al., 2010, 2012a).”
BackgroundSelf-citationGiusto, E., Donegà, M., Cossetti, C., & Pluchino, S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.009 · Cited by 100
“…and pathological recovery through a number of bystander mechanisms that grafted NPCs employ to neutralize free radicals, inflammatory cytokines, excitotoxins, lipases peroxidases and other toxic metabolites released following an ischaemic event (Bacigaluppi et al., 2009; Ourednik et al., 2002).”
BackgroundInfluentialZheng, X., Zhang, L., Kuang, Y., Venkataramani, V., Jin, F., Hein, K., Zafeiriou, M. P., Lenz, C., Moebius, W., Kilic, E., et al. (2021) · Translational Stroke Research · doi:10.1007/s12975-020-00814-z · Cited by 86
Self-citationCurrent Challenges for the Advancement of Neural Stem Cell Biology and Transplantation Research
Reekmans, K., Praet, J., Daans, J., Reumers, V., Pauwels, P., der Linden, A. V., Berneman, Z. N., & Ponsaerts, P. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9266-2 · Cited by 91
“recovery results [66].”
Cell Therapy for Neonatal Hypoxic–Ischemic Encephalopathy
Pimentel‐Coelho, P. M., & Méndez‐Otero, R. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0403 · Cited by 91
Hermann, D. M., Peruzzotti‐Jametti, L., Schlechter, J., Bernstock, J. D., Doeppner, T. R., & Pluchino, S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00291 · Cited by 95
“Despite the fact that systemic NPC transplantation yields fewer cells in the ischemic brain parenchyma, current evidence suggests that intravenous injection is clearly able to promote neuronal/glial survival at delayed time-points (Bacigaluppi et al., 2009; Doeppner et al., 2012).”
BackgroundInfluentialSelf-citationThe role of the immune system in central nervous system plasticity after acute injury
Peruzzotti‐Jametti, L., Donegà, M., Giusto, E., Mallucci, G., Marchetti, B., & Pluchino, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.036 · Cited by 91
“Similarly, other therapeutic approaches (including the transplantation of NSC) have shown to be effective in inducing restorative effects in a mouse model of stroke by reducing excessive microglial activation (Bacigaluppi et al., 2009).”
Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives
Rahman, M. M., Islam, M. R., Islam, M. T., Harun-Or-Rashid, M., Islam, M., Abdullah, S., Uddin, M., Das, S. K., Rahaman, M. S., Ahmed, M., et al. (2022) · Biology · doi:10.3390/biology11010147 · Cited by 93
“found evidence that the replacement of damaged or dead cells may not represent the fundamental mechanism underlying the apparent benefits following SC transplantation, indicating that immune modulation also plays a vital role in the observed improvements [95].”
BackgroundRole of Nogo-A in neuronal survival in the reperfused ischemic brain
Kilic, E., ElAli, A., Kilic, Ü., Guo, Z., Ugur, M., Uslu, U., Bassetti, C. L., Schwab, M. E., & Hermann, D. M. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.268 · Cited by 79
Self-citationFranchi, S., Valsecchi, A. E., Borsani, E., Procacci, P., Ferrari, D., Zaffa, C., Sartori, P., Rodella, L. F., Vescovi, A. L., Maione, S., et al. (2012) · Pain · doi:10.1016/j.pain.2012.01.008 · Cited by 78
“S. Franchi et al. / PAIN 153 (2012) 850–861 851 Moreover, in these experiments, cells were administered directly at the lesion site (intraspinal or perilesional), thus possibly overloading the system [22,27].”
Doeppner, T. R., Ewert, T. A. S., Tönges, L., Herz, J., Zechariah, A., ElAli, A., Ludwig, A., Giebel, B., Nagel, F., Dietz, G. P. H., et al. (2012) · Stem Cells · doi:10.1002/stem.1098 · Cited by 87
Self-citationLattanzi, A., Neri, M., Maderna, C., di Girolamo, I., Martino, S., Orlacchio, A., Amendola, M., Naldini, L., & Gritti, A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq099 · Cited by 81
Bălşeanu, T. A., Buga, A.-M., Cătălin, B., Wagner, D., Boltze, J., Zăgrean, A., Reymann, K. G., Schaebitz, W., & Popa‐Wagner, A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00130 · Cited by 79
“Anotherpointthatshouldbeconsideredinfuturestudiesisaprob-lemassociatedwithautologoustransplantationofBMMSCsin”
Meneghini, V., Frati, G., Sala, D., Cicco, S. D., Luciani, M., Cavazzin, C., Paulis, M., Mentzen, W. I., Morena, F., Giannelli, S. G., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0414 · Cited by 77
Vasconcelos-dos-Santos, A., Rosado-de-Castro, P. H., de Souza, S. A. L., Silva, J. C., Ramos, A. B., de Freitas, G. R., da Fonseca, L. M. B., Gutfilen, B., & Méndez‐Otero, R. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.02.002 · Cited by 80
Opportunities and Challenges: Stem Cell‐Based Therapy for the Treatment of Ischemic Stroke
Tang, Y., Ma, Y., Zhang, Z., Wang, Y., & Yang, G. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12386 · Cited by 84
Roles of neural stem cells in the repair of peripheral nerve injury
Hu, C.-D., Wang, Y., Wang, C., Lu, C., & Peng, J. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.221171 · Cited by 83
“Recent advances in the field of tissue engineering have allowed for the testing of the immunomodulatory properties of NSCs in several nervous system diseases (Bacigaluppi et al., 2009).”
BackgroundTherapeutic Effects of hMAPC and hMSC Transplantation after Stroke in Mice
Mora-Lee, S., Sirerol-Piquer, M. S., Gutiérrez-Pérez, M., Gómez‐Pinedo, U., Roobrouck, V. D., Lopez, T. V., Casado-Nieto, M., Abizanda, G., Rábena, M. T., Verfaillie, C. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043683 · Cited by 85
Mechanisms and Functional Significance of Stroke-Induced Neurogenesis
Marlier, Q., Verteneuil, S., Vandenbosch, R., & Malgrange, B. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00458 · Cited by 85
“Moreover, upon intravenous transplantation of adult mouse NSCs after stroke, only a few percent of cells survive in the brain (Bacigaluppi et al., 2009).”
BackgroundSubventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity
Butti, E., Bacigaluppi, M., Rossi, S., Cambiaghi, M., Bari, M., Cebrian Silla, A., Brambilla, E., Musella, A., De Ceglia, R., Teneud, L., et al. (2012) · Brain · doi:10.1093/brain/aws194 · Cited by 73
Self-citationShin, J. E., Jung, K., Kim, M., Hwang, K., Lee, H.-J., Kim, I., Lee, B. H., Lee, I.-S., & Park, K. I. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0054-9 · Cited by 73
Human induced pluripotent stem cells improve recovery in stroke-injured aged rats
Tatarishvili, J., Oki, K., Monni, E., Koch, P., Memanishvili, T., Buga, A.-M., Verma, V., Popa‐Wagner, A., Brüstle, O., Lindvall, O., et al. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-140404 · Cited by 72
“…several mech-28 anisms, such as neuronal replacement (Daadi et al.,29 2009, 2008), modulation of inflammation (Bacigaluppi30 et al., 2009; Horie et al., 2011; Lee et al., 2008), neu-31 roprotection (Bacigaluppi et al., 2009), or stimulation32 of angiogenesis (Chen et al., 2003; Horie et al., 2011”
The spleen may be an important target of stem cell therapy for stroke
Wang, Z., He, D., Zeng, Y., Zhu, L., Yang, C., Lu, Y.-J., Huang, J., Cheng, X., Huang, X., & Tan, X. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1400-0 · Cited by 72
Reitmeir, R., Kilic, E., Reinboth, B. S., Guo, Z., ElAli, A., Zechariah, A., Kilic, Ü., & Hermann, D. M. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0914-z · Cited by 69
“Thus, the borders of both structures were outlined and their surface analyzed (in case of corpus callosum up to 1 mm lateral to midline, thus reflecting areas on coronal brain sections [3]).”
BackgroundSelf-citationDonega, V., van Velthoven, C. T. J., Nijboer, C. H. A., Kavelaars, A., & Heijnen, C. J. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.3 · Cited by 81
Huang, B. Y., Jiang, X., Zhang, T., Hu, Y., Tabata, Y., Chen, Z., Pluchino, S., & Gao, J. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.073 · Cited by 72
New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies
Cossetti, C., Alfaro‐Cervelló, C., Donegà, M., Tyzack, G. E., & Pluchino, S. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1341-8 · Cited by 71
“On the other hand, the sub-acute systemic injection of NPCs in MCAo mice produced significant down-regulation in the ischemic brain hemisphere of multiple RNAs involved in inflammation, including lfng, Tnfa, ll1b and Lepr (Bacigaluppi et al. 2009).”
The Rise of Cell Therapy Trials for Stroke: Review of Published and Registered Studies
Rosado-de-Castro, P. H., Pimentel‐Coelho, P. M., da Fonseca, L. M. B., de Freitas, G. R., & Méndez‐Otero, R. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0089 · Cited by 75
“Similarly, despite the low levels of engraftment and neuronal differentiation in the ischemic brain, intravenously transplanted adult NSPC showed neuroprotective and antiinflammatory effects in a rodent model of stroke [42].”
BackgroundNeri, M., Ricca, A., di Girolamo, I., Alcalá-Franco, B., Cavazzin, C., Orlacchio, A., Martino, S., Naldini, L., & Gritti, A. (2011) · Stem Cells · doi:10.1002/stem.701 · Cited by 67
Effects of resveratrol on hydrogen peroxide-induced oxidative stress in embryonic neural stem cells.
Konyalıoğlu, S., Armağan, G., Yalçın, A., Özkaya, Ç. A., & Dağcı, T. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.06.001 · Cited by 78
“In animal models of neurodegenerative diseases, transplantation of stem cells or their derivatives induces the regeneration of the lost neurons and glial cells and elicits remyelination, has trophic effects, and modulates inflammation [14-17] .”
Minnerup, J., Kim, J. B., Schmidt, A., Diederich, K., Bauer, H., Schilling, M., Strecker, J., Ringelstein, E. B., Sommer, C., Schöler, H. R., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.599282 · Cited by 67
Stem cell therapies in preclinical models of stroke associated with aging
Popa‐Wagner, A., Buga, A.-M., Doeppner, T. R., & Hermann, D. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00347 · Cited by 71
“Despite the less potent effects on neuronal survival, NPC delivery reduced glial scar formation in the surrounding of neocortical strokes (Bacigaluppi et al., 2009) and increased axonal plasticity in the contralesional motor cortex (Andres et al., 2011).”
BackgroundInfluentialSelf-citationHermann, D. M., Kleinschnitz, C., & Gunzer, M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.04.015 · Cited by 75
Self-citationExtracellular Membrane Vesicles and Immune Regulation in the Brain
Cossetti, C., Smith, J. A., Iraci, N., Leonardi, T., Alfaro-Cervello, C., & Pluchino, S. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00117 · Cited by 63
“…models of stroke documented that, thanks to their reactivity to CCL2/CCR2 and CXCL12/CXCR4 axes, NPCs migrate in the perilesional area and persist there in an undifferentiated phenotype (Imitola et al., 2004; Darsalia et al., 2007; Bacigaluppi et al., 2009; Sun et al., 2010; Andres et al., 2011).”
Background
Metadata
- Authors
- Bacigaluppi, M., Pluchino, S., Jametti, L. P., Kilic, E., Kilic, Ü., Salani, G., Brambilla, E., West, M. J., Comi, G., Martino, G., & Hermann, D. M.
- Affiliations
- University Hospital Zurich (CH)
- IRCCS Ospedale San Raffaele (IT)
- Aarhus University (DK)
- Corresponding author
- Hermann, Dirk M.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-16
- Volume
- 132
- Issue
- 8
- Pages
- 2239-2251
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2117381245
- Cited by
- 350
- References
- 59
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 15 · 2022: 17 · 2021: 14 · 2020: 26 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 29 · 2015: 27 · 2014: 33 · 2013: 29 · 2012: 32
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (112056, 3200B0)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neural stem cell transplantation, ischemic stroke, middle cerebral artery occlusion, bystander effect, neuronal apoptosis, glial scar formation, neuroinflammation, delayed neuronal death, neurological recovery, gene expression
- MeSH terms
- Animals, Astrocytes, Atrophy, Brain, Cell Survival, Cicatrix, Corpus Callosum, Disease Models, Animal, Gene Expression Regulation, Inflammation, Male, Mice, Inbred C57BL, Neurons, Disease Progression, Stroke, Gene Expression Profiling, Stem Cell Transplantation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.